@mj-mair.bsky.social @zoltanspiro.bsky.social @lbg.ac.at @meduniwien.ac.at @medunigraz.at @i-med.ac.at @jku.at

📸 ATTRACT General Assembly & Retreat - great discussions, clear priorities, and exciting next steps ahead 🚀

Proud of our interdisciplinary team driving precision oncology forward.

#NeuroOncology #ClinicalTrials #CancerResearch #btsm #glioblastoma

🎉 Happy new year - taking stock of the #ATTRACT network 🇦🇹

🗺️ All participating sites across Austria, working together to enable equitable trial access.
🧠 Biobanking + 28-drug testing → functional precision oncology.

🔗 Learn more: tinyurl.com/2umu6auv
#Glioblastoma #ClinicalTrials #NeuroOncology

#glioblastoma #btsm #neurooncology

@zoltanspiro.bsky.social @mj-mair.bsky.social @lbg.ac.at @meduniwien.ac.at @medunigraz.at @i-med.ac.at @jku.at

Ex vivo drug screening on patient-derived tumor material to advance functional precision in oncology: an overview on current approaches and unresolved challenges Over the past two decades, oncology has undergone a profound transformation, largely driven by the rise of targeted therapies and immune-modulating agents. By tailoring treatments to the molecular pro...

🎄 Festive publication alert from ATTRACT 💫

Our new review in #CancerTreatmentReviews highlights how ex vivo drug screening can support #FunctionalPrecisionOncology and inform #ClinicalTrials like ATTRACT.

doi.org/10.1016/j.ct...

✨ Wishing all a warm and restful holiday season - see you in 2026!

🏔️ Salzburg joins the #ATTRACT network - and the 1st tumor sample is already on the way!

🇦🇹 Expanding precision oncology access for #glioblastoma patients.
🧠 Biobanking + 28-drug testing → personalized insights.

👏 Thanks to the Salzburg team & @lbg.ac.at!
#NeuroOncology #PrecisionMedicine #btsm

🚀 Another milestone for expanding nationwide access to precision care for #glioblastoma! 🇦🇹
The first patient included in our biobanking program at Klinik Donaustadt has been randomized 🎉

👏 Thanks to the local team, @lbg.ac.at & all partners.

#NeuroOncology #ClinicalTrials #btsm

🧠 Bringing #PrecisionOncology to life!

🚀 At #EANO2025, Anna Sophie Berghoff presented the design of the #ATTRACT trial - testing 28 drugs on patient-derived tumor cells to personalize #glioblastoma therapy.

👏 Thanks to @lbg.ac.at & all partners in 🇦🇹!
#NeuroOncology #ClinicalTrials #btsm

Personalized targeted glioblastoma therapies by ex vivo drug screening: Study protocol of the Advanced brain Tumor TheRApy Clinical Trial (ATTRACT) AbstractBackground. Novel approaches to guide personalized treatment in glioblastoma are urgently needed. Given the poor predictive value of genetic biomar

🎯 How can we make #PrecisionMedicine real for #glioblastoma?

🧠 The #ATTRACT trial tests 28 drugs on patient-derived cells & uses a molecular tumor board for #personalized therapy recommendation.

📚 Read our protocol paper in #NeuroOncology Advances: doi.org/10.1093/noaj...

📲 Follow us for updates!

🚀 #ATTRACT wächst!

⛔️ #KlinischeStudien sollten nicht nur auf wenige Zentren beschränkt sein. Deshalb erweitern wir unser #Biobanking, um Patient:innen mit #Glioblastom in ganz #Österreich 🇦🇹 Zugang zu ATTRACT zu ermöglichen.

🎉 Meilenstein: 1. Patient in Wiener Neustadt eingeschlossen!

🚀 #ATTRACT is growing!

⛔️ #ClinicalTrials shouldn’t be limited to a few centers. Therefore, we are expanding our #biobanking to give #glioblastoma patients across #Austria 🇦🇹 access to ATTRACT.

🎉 Milestone: 1st patient enrolled in Wiener Neustadt!

#NeuroOncology #PrecisionMedicine #CancerResearch

Die KFG ATTRACT YouTube video by Ludwig Boltzmann Gesellschaft

🧠 What is #ATTRACT – and how could it improve #glioblastoma care? This video (🇩🇪 with 🇬🇧 subs) explains how we test 28 drugs on tumor cells & personalize therapy.

Made by @lbg.ac.at w/ Anna Berghoff (ATTRACT Head), @mj-mair.bsky.social (Deputy Head) & Matthias Preusser (Mentor) 🚀
youtu.be/NfxxMZ_xmF4

🚀 We’re launching the BlueSky presence of #ATTRACT - a 🇦🇹 Clinical Research Group investigating ex-vivo drug screening 💊 for personalized #glioblastoma treatment, funded by @lbg.ac.at with @meduniwien.ac.at as lead institution.
➡️ Follow us for further insights!
🧠 #GlioblastomaAwarenessDay #NeuroOnc